arrow
F

Friederike Holze

University Hospital Basel
H指数:28
被引数:2,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Investigating molecular and hemodynamic effects of LSD in the human brain

探究LSD在人类大脑中的分子和血流动力学效应

2026-10-120
PRE
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants

4-溴-2,5-二甲氧基苯乙胺(2C-B)的急性剂量依赖性效应与3,4-亚甲二氧基甲基苯丙胺(MDMA)和裸盖菇素在双盲、安慰剂对照研究中的比较,在健康受试者中进行

2026-04-280
OAAI
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings

将神秘体验问卷纳入更广泛的心理学测量框架:迷幻体验量表的英语验证及在两种受控环境下的裸盖菇素和麦角酸二乙胺体验比较

2026-04-260
OA
Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness—a psychometric analysis using the PES100 in controlled psychedelic studies

神秘动力学:作为与神秘合一相关的关键特征——更新、光芒四射的光线以及自我解体——一项使用PES100在受控迷幻研究中的心理测量分析

2026-03-310
OA
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research

3D-ASCr量表:对用于迷幻研究的意识改变状态量表5D(11)-ASC核心维度的再验证

2025-12-260
OA
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

在健康参与者的随机,双盲,安慰剂对照交叉研究中,麦斯卡林,麦角酸二乙胺和psilocybin的比较急性作用

2023-05-2544
OAAI